Health system strengthening and hypertension management in China
Tóm tắt
Non-communicable diseases are the leading causes of global burden of diseases, and hypertension is one of the most important risk factors. Hypertension prevalence doubled in China in the past decade and affects more than 300 million Chinese people. In the review we systematically searched peer-reviewed publications that link health system level factors with hypertension management in China and provide the current knowledge on how to improve a country’s health system to manage the hypertension epidemic. A framework was developed to guide the review. The database of PubMed, CNKI were systematically searched from inception to April 13, 2016. Two authors independently screened the searched results for inclusion, conducted data extraction and appraised the quality of studies. Key findings were described according to the framework. Five hundred seventy-two publications were identified, where 11 articles were left according to the inclusion and exclusion criteria. The study periods range from 2010 to 2015. All about 11 researches linked health system factors to the outcome of hypertension management. And the outcomes were just focused on the awareness, treatment and control of hypertension but not hypertension incidence. One study is about the role of health system governance, investigating the performance of different organized community health care centers; three studies were about health financing comparing differences in insurance coverage; three studies were about health information practicing the hypertension guidelines of China or the WHO, and the rest three about mechanisms of health service delivery. No researches were identified about physical resources for health and human resources for health. Hypertension prevalence has been rising rapidly in China and the management of hypertension in China is a detection problem rather than treatment problem. Limited evidence shows the positive effect of health system factors on hypertension management and joint efforts from health system and epidemiological researchers are warranted to extend knowledge in this area.
Tài liệu tham khảo
WHO. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
Lozano R, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.
UN General Assembly. Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. New York: United Nations; 2011.
Lewington S, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–13.
Lim SS, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.
WHO. A global brief on hypertension-silent killer, global public health crisis. 2013.
Mendis S, et al. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ. 2010;88(6):412–9.
Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611–9.
James PA, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
Xu W, et al. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158.
WHO. Everybody’s business: Strengthening health systems to improve health outcomes: WHO’s framework for action. Geneva: World Health Organization; 2007.
Maimaris W, et al. The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Med. 2013;10(7):e1001490.
Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41.
He J, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009;374(9703):1765–72.
WHO. Monitoring the building blocks of health systems. 2010.
WHO. Checklist and Indicators for Monitoring Progress in the Development of IHR Core Capacities in States Parties. 2005.
Gu D, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in China. Hypertension. 2002;40(6):920–7.
Reynolds K, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21(7):1273–81.
Dong G, et al. Prevalence, awareness, treatment, and control of hypertension in rural adults from Liaoning Province, northeast China. Hypertens Res. 2007;30(10):951–8.
Li H, et al. Prevalence, awareness, treatment, and control of hypertension in rural China: results from Shandong Province. J Hypertens. 2010;28(3):432–8.
Li D, et al. Hypertension burden and control in mainland China: Analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–44.
Guo J, et al. The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults. J Hypertens. 2015;33(8):1688–96.
Basu S, Millett C. Social Epidemiology of Hypertension in Middle-Income Countries: Determinants of Prevalence, Diagnosis, Treatment, and Control in the WHO SAGE Study. Hypertension. 2013;62(1):18–26.
Lloyd-Sherlock P, et al. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43(1):116–28.
Wang J, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27(11):1355–61.
Bi Z, et al. Hypertension prevalence, awareness, treatment, and control and sodium intake in Shandong Province, China: baseline results from Shandong-Ministry of Health Action on Salt Reduction and Hypertension (SMASH), 2011. Prev Chronic Dis. 2014;11:E88.
Wang H, et al. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in Southern China: a community-based, cross-sectional survey. PLoS One. 2013;8(5):e62469.
Zhang J, et al. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Bai ethnic group in rural China: the Yunnan Minority Eye Study. PLoS One. 2013;8(8):e70886.
Zhao Y, et al. Trends in population blood pressure and prevalence, awareness, treatment, and control of hypertension among middle-aged and older adults in a rural area of Northwest China from 1982 to 2010. PLoS One. 2013;8(4):e61779.
Hou Z, Meng Q, Zhang Y. Hypertension Prevalence, Awareness, Treatment, and Control Following China’s Healthcare Reform. Am J Hypertens. 2015;29(4):428–31.
Zeng XY, et al. The study of management of hypertensive people aged 35 and over in communities in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2013;47(11):1014–9.
Department, H. National essential public health services (2009). 2009. p. 1.
Wong MCS. Performance Comparison among the Major Healthcare Financing Systems in Six Cities of the Pearl River Delta Region, Mainland China. PLOS ONE. 2012;7(9):1–3.
WHO. Prevention of Cardiovascular Disease. 2007.
WHO. Integrated Management of Cardiovascular Risk. 2002.
Liu L. Guidelines for prevention and treatment of hypertension in China. Chin J Hypertens. 2011;19(8):701–43.
Wang Z, Wang X, Zhang L. Community hypertension control: evaluation of the effect of blood pressure management. Chin J Epidemiol. 2010;31(1):1–4.
Li G. Effects of Guideline-based Hypertension Management in Rural Areas of Guangdong Province. Chin Med J. 2015;128(6):799–803.
Lu C, et al. Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health. 2015;15(1):33.
Yun R, Yan LL. Effectiveness of a Community-Based Individualized Lifestyle Intervention Among Older Adults With Diabetes and Hypertension, Tianjin, China, 2008–2009. Prev Chronic Dis. 2014;11:1–7.
Niu H, et al. Differences and determinants in access to essential public health services in China: a case study with hypertension people and under-sixes as target population. Chin Med J (Engl). 2014;127(9):1626–32.
Gu D, et al. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study. PLoS Med. 2015;12(8):e1001860.